Gabelli Funds’s OCATA THERAPEUTICS, INC. COMMON STOCK OCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-1,685,200
Closed -$14.2M 1183
2015
Q4
$14.2M Buy
+1,685,200
New +$11.3M 0.09% 316

Gabelli Funds's OCAT Position: Q1 2016 in Review

Gabelli Funds sold out of OCATA THERAPEUTICS, INC. COMMON STOCK (OCAT) in Q1 2016, closing a stake of 1,685,200 shares — an estimated $14.2M sold.

Gabelli Funds first reported a position in OCAT in Q4 2015 and held it in 1 quarter. The position peaked at $14.2M in Q4 2015. 1 fund tracked by Wall St. Rank holds OCAT as of Q1 2016.

  • Gabelli Funds reported no remaining OCATA THERAPEUTICS, INC. COMMON STOCK position as of Q1 2016 after selling out during the quarter.
  • Gabelli Funds sold 1,685,200 OCATA THERAPEUTICS, INC. COMMON STOCK shares in Q1 2016, an estimated $14.2M.
  • Gabelli Funds first reported a position in OCATA THERAPEUTICS, INC. COMMON STOCK in Q4 2015 and held it in 1 quarter.
  • Gabelli Funds's OCATA THERAPEUTICS, INC. COMMON STOCK position peaked at $14.2M in Q4 2015.
  • 1 fund tracked by Wall St. Rank held OCATA THERAPEUTICS, INC. COMMON STOCK as of Q1 2016.

Based on Gabelli Funds's 13F filing for Q1 2016, filed 5 May 2016.